FDB OptimiseRxNews

EMIS National User Group 2018

By September 12, 2018 No Comments

EMIS National User Group 2018This week the FDB OptimiseRx team were at EMIS National User Group in Birmingham celebrating 25 years of EMIS users coming together to share user experience and best practice in Primary Care.

During the two-day event, Polly Shepperdson, Senior Product Manager for OptimiseRx, and Nicholas Meese, Product Manager, ran a workshop for EMIS Web users ‘Who is Responsible for Prescribing’, prompting discussion around the relationships and human factors involved in shared patient responsibility in general practice. In particular, looking at who is making the prescribing decision and who is responsible for the management of the patient once it has been issued. The workshop concluded with feedback on future plans to support medicines optimisation for high volume repeat prescriptions (1000+ per week, per practice*) care home prescribing and how population analytics can play a role.

Throughout the event, the team met GPs and other prescribers using OptimiseRx in their practice and received the following feedback:

 ‘OptimiseRx messages are not [invasive], and suggestions are easily accepted and part of the workflow.’

 ‘I like OptimiseRx because it supports complex clinical prescribing decisions in a time- sensitive environment to support safe prescribing. ’

 ‘Really pleased to hear the progress on the changes to OptimiseRx in the next version of EMIS Web.’

 ‘The GPs love it, they use it a lot, they’ve aligned much better to this latest solution.’

OptimiseRx has been integrated with EMIS since the medicines optimisation solution was first launched and is used by over 3,500 EMIS practices. The solution combines evidence-based best practice, safety and cost-effective prescribing messages, and delivers them in real time during the prescribing workflow.

 

FDB OptimiseRx – The leading medicines optimisation solution for primary care in the UK

 

Find out more, download the Optimise brochure

 

 

* ‘Average number of repeat prescriptions generated in a week by practices completing our survey was 1,091′ https://www.kingsfund.org.uk/sites/default/files/field/field_publication_file/Understanding-GP-pressures-Kings-Fund-May-2016.pdf

 

© First Databank UK Ltd is a private company registered in England, No. 01880682. Registered office: Swallowtail House, Grenadier Road, Exeter, EX1 3LH. All trademarks mentioned herein belong to their respective holders.